News for hackers. Stuff that matters.
Re:Why huge gains in drug discovery tech have led to longer ... by steve-howard on Monday March 07, 2016 @10:05PM (#11243320)
>And you'll have to explain Rexulti and Abilify to me. Abilify isn't an antidepressant, it's an antipsychotic.

I hadn't heard about Rexulti until today, but Abilify is heavily marketed as an adjunct therapy for treatment-resistant depression.

There are no comments on this comment yet.